封面
市场调查报告书
商品编码
1855931

2025年全球新生儿即时检测市场报告

Neonatal Point Of Care Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,新生儿即时检测市场发展迅速,预计从2024年的11.6亿美元成长到2025年的13.2亿美元,复合年增长率达14.6%。这一增长主要受以下因素驱动:新生儿疾病发病率上升、对快速诊断结果的需求增加、人们对新生儿健康风险的认识不断提高、早产率上升以及医院越来越多地采用床边检测。

预计未来几年新生儿即时检测市场将快速成长,到2029年市场规模将达到22.7亿美元,复合年增长率(CAGR)为14.4%。预测期内的成长预计将受到以下因素的推动:对个人化新生儿护理的需求不断增长、可携式检测设备的普及率不断提高、对早期疾病检测的偏好日益增强、对降低新生儿死亡率的关注度不断提高,以及对先进诊断工具的投资不断增加。预测期内的主要趋势包括:生物感测器技术的进步、基于微流体技术的诊断平台的创新、多重检测研发的增加、无线新生儿监护系统的开发以及照护现场分子检测技术的创新。

预计对远端患者监护日益增长的需求将推动新生儿即时检测(POC​​)市场的扩张。远端患者监护利用数位技术连接患者与医疗专业人员,无需患者亲自到场即可获得医疗保健服务。这种需求源自于对及时便捷医疗服务的需求,尤其是在医疗基础设施有限的偏远和欠发达地区。新生儿即时检测在远距监护中发挥关键作用,它可在床边提供即时诊断结果,使医护人员能够快速识别和处理新生儿的危重健康状况,而无需依赖中心检查室。例如,根据美国医疗科技公司Rock Health在2023年2月进行的一项调查,76%的55岁及以上受访者曾使用过远端医疗,80%的受访者在其一生中的某个阶段接受远端医疗医疗服务,高于2021年的72%。因此,对远端患者监护日益增长的需求正在推动新生儿即时检测市场的成长。

新生儿即时检测(POC​​)市场的主要企业正在建立策略联盟,以扩大诊断服务的覆盖范围并改善新生儿早期医疗保健。策略合作是指不同组织之间为了实现通用目标而建立的伙伴关係,这些组织汇集了各自的资源和专业知识。例如,2025年1月,总部位于荷兰的样本和检测技术供应商QIAGEN与总部位于英国的基因组医学伙伴关係Genomics England建立了合作关係。此次合作将支持「世代研究」(Generation Study)的推出,计划旨在对英国10万名新生儿的基因组进行定序,并识别200多种可治疗的遗传疾病。 QIAGEN将为POC定序测试中评估的基因提供具有临床意义的遗传变异数据,从而加快分析和结果报告的速度。该研究计画于2024年10月正式启动,预计将对英国每年约3,000名新生儿所患的疾病的早期发现和治疗产生正面影响。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球新生儿即时检测:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 终端用户产业分析
  • 全球新生儿即时侦测市场:成长率分析
  • 全球新生儿即时检测市场表现:规模与成长,2019-2024年
  • 全球新生儿即时检测市场预测:规模与成长,2024-2029年,2034年
  • 全球新生儿即时检测:潜在市场规模 (TAM)

第六章 市场细分

  • 全球新生儿即时检测市场依产品、效能及预测划分,2019-2024年、2024-2029年、2034年
  • 装置
  • 侦测
  • 全球新生儿即时检测市场依检测类型、效能及预测划分,2019-2024年、2024-2029年、2034年
  • 新生儿胆红素检测
  • 新生儿代谢筛检
  • 血糖值检测
  • 传染病筛检
  • 电解质测试
  • 其他测试类型
  • 全球新生儿即时检测市场(按最终用户、性能和预测划分,2019-2024年、2024-2029年、2034年)
  • 医院
  • 诊断中心
  • 妇产科和专科诊所
  • 其他最终用户
  • 全球新生儿即时检测市场:按设备、类型、性能和预测进行细分,2019-2024年、2024-2029年、2034年
  • 血气分析仪
  • 胆红素仪
  • 血糖仪
  • 血液分析仪
  • 多专案监视器
  • 全球新生儿即时检测市场:按检测方法、类型、性能和预测进行细分,2019-2024年、2024-2029年、2034年
  • 胆红素测定
  • 葡萄糖测定
  • 感染疾病试验
  • 血液学检测
  • 心臟标记检测
  • 电解质测定
  • 血气分析

第七章 区域和国家分析

  • 全球新生儿即时检测市场:区域表现及预测,2019-2024年、2024-2029年及2034年
  • 全球新生儿即时检测市场:国家、绩效及预测,2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 新生儿即时侦测市场:竞争格局
  • 新生儿即时检测市场:公司概况
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • Drager Ag Co. Kg
  • Bio-Rad Laboratories Inc.
  • Masimo Corporation
  • QIAGEN Inc.
  • Radiometer Ltd.
  • Contec Medical Systems Co. Ltd.
  • Owen Mumford Ltd.
  • Nova Biomedical
  • Heal Force Bio Meditech Holdings Ltd.
  • Edan Instruments Inc.
  • Trivitron Healthcare
  • Bistos Co. Ltd.
  • Bilimetrix SrI
  • GINEVRI srl
  • Hadleigh Health Technologies

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年新生儿即时检测市场:提供新机会的国家
  • 2029年新生儿即时检测市场:新兴细分市场机会
  • 2029年新生儿即时检测市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38583

Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.

The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The neonatal point of care testing market research report is one of a series of new reports from The Business Research Company that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. Growth in the historic period was driven by the rising incidence of neonatal disorders, increasing demand for rapid diagnostic results, greater awareness of neonatal health risks, higher prevalence of preterm births, and growing hospital adoption of bedside testing.

The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. Growth in the forecast period is expected to be supported by rising demand for personalized neonatal care, increased adoption of portable testing devices, growing preference for early disease detection, heightened focus on reducing neonatal mortality rates, and greater investment in advanced diagnostic tools. Key trends anticipated for the forecast period include advancements in biosensor technology, innovation in microfluidic-based diagnostic platforms, increased research and development for multiplex assays, development of wireless neonatal monitoring systems, and innovation in point-of-care molecular testing.

The growing demand for remote patient monitoring is anticipated to support the expansion of the neonatal point of care testing market. Remote patient monitoring refers to the use of digital technology to provide healthcare services by connecting patients with medical professionals without requiring in-person visits. This demand is rising due to the need for timely, accessible care, particularly in remote and underserved areas where medical infrastructure may be limited. Neonatal point of care testing plays a key role in remote monitoring by delivering immediate diagnostic results at the bedside, allowing healthcare providers to rapidly identify and address critical health conditions in newborns without depending on central laboratories. For example, in February 2023, a survey conducted by Rock Health, a health technology company based in the United States, showed that seventy-six percent of respondents over the age of fifty-five had used telemedicine, while eighty percent of all participants had accessed healthcare through telemedicine at some point in their lives, up from seventy-two percent in 2021. Therefore, the rising demand for remote patient monitoring is driving growth in the neonatal point of care testing market.

Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.

In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company's growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.

Major players in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Konica Minolta Inc., Drager Ag Co. Kg, Bio-Rad Laboratories Inc., Masimo Corporation, QIAGEN Inc., Radiometer Ltd., Contec Medical Systems Co. Ltd., Owen Mumford Ltd., Nova Biomedical, Heal Force Bio Meditech Holdings Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.I, GINEVRI srl, Hadleigh Health Technologies.

North America was the largest region in the neonatal point of care testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal point of care testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Point Of Care Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal point of care testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Assay
  • 2) By Test Type: Neonatal Bilirubin Testing; Newborn Metabolic Screening; Blood Glucose Testing; Infectious Disease Screening; Electrolyte Testing; Other Test Types
  • 3) By End-Users: Hospitals; Diagnostic Centers; Maternity And Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Instruments: Blood Gas Analyzers; Bilirubinometers; Glucose Meters; Hematology Analyzers; Multiparameter Monitors
  • 2) By Assay: Bilirubin Assays; Glucose Assays; Infectious Disease Assays; Hematology Assays; Cardiac Marker Assays; Electrolyte Assays; Blood Gas Assays
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Konica Minolta Inc.; Drager Ag Co. Kg; Bio-Rad Laboratories Inc.; Masimo Corporation; QIAGEN Inc.; Radiometer Ltd.; Contec Medical Systems Co. Ltd.; Owen Mumford Ltd.; Nova Biomedical; Heal Force Bio Meditech Holdings Ltd.; Edan Instruments Inc.; Trivitron Healthcare; Bistos Co. Ltd.; Bilimetrix S.r.I; GINEVRI srl; Hadleigh Health Technologies.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neonatal Point Of Care Testing Market Characteristics

3. Neonatal Point Of Care Testing Market Trends And Strategies

4. Neonatal Point Of Care Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neonatal Point Of Care Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neonatal Point Of Care Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neonatal Point Of Care Testing Market Growth Rate Analysis
  • 5.4. Global Neonatal Point Of Care Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neonatal Point Of Care Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neonatal Point Of Care Testing Total Addressable Market (TAM)

6. Neonatal Point Of Care Testing Market Segmentation

  • 6.1. Global Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Assay
  • 6.2. Global Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neonatal Bilirubin Testing
  • Newborn Metabolic Screening
  • Blood Glucose Testing
  • Infectious Disease Screening
  • Electrolyte Testing
  • Other Test Types
  • 6.3. Global Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Maternity And Speciality Clinics
  • Other End-Users
  • 6.4. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Gas Analyzers
  • Bilirubinometers
  • Glucose Meters
  • Hematology Analyzers
  • Multiparameter Monitors
  • 6.5. Global Neonatal Point Of Care Testing Market, Sub-Segmentation Of Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bilirubin Assays
  • Glucose Assays
  • Infectious Disease Assays
  • Hematology Assays
  • Cardiac Marker Assays
  • Electrolyte Assays
  • Blood Gas Assays

7. Neonatal Point Of Care Testing Market Regional And Country Analysis

  • 7.1. Global Neonatal Point Of Care Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neonatal Point Of Care Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neonatal Point Of Care Testing Market

  • 8.1. Asia-Pacific Neonatal Point Of Care Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neonatal Point Of Care Testing Market

  • 9.1. China Neonatal Point Of Care Testing Market Overview
  • 9.2. China Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neonatal Point Of Care Testing Market

  • 10.1. India Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neonatal Point Of Care Testing Market

  • 11.1. Japan Neonatal Point Of Care Testing Market Overview
  • 11.2. Japan Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neonatal Point Of Care Testing Market

  • 12.1. Australia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neonatal Point Of Care Testing Market

  • 13.1. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neonatal Point Of Care Testing Market

  • 14.1. South Korea Neonatal Point Of Care Testing Market Overview
  • 14.2. South Korea Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neonatal Point Of Care Testing Market

  • 15.1. Western Europe Neonatal Point Of Care Testing Market Overview
  • 15.2. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neonatal Point Of Care Testing Market

  • 16.1. UK Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neonatal Point Of Care Testing Market

  • 17.1. Germany Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neonatal Point Of Care Testing Market

  • 18.1. France Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neonatal Point Of Care Testing Market

  • 19.1. Italy Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neonatal Point Of Care Testing Market

  • 20.1. Spain Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neonatal Point Of Care Testing Market

  • 21.1. Eastern Europe Neonatal Point Of Care Testing Market Overview
  • 21.2. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neonatal Point Of Care Testing Market

  • 22.1. Russia Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neonatal Point Of Care Testing Market

  • 23.1. North America Neonatal Point Of Care Testing Market Overview
  • 23.2. North America Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neonatal Point Of Care Testing Market

  • 24.1. USA Neonatal Point Of Care Testing Market Overview
  • 24.2. USA Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neonatal Point Of Care Testing Market

  • 25.1. Canada Neonatal Point Of Care Testing Market Overview
  • 25.2. Canada Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neonatal Point Of Care Testing Market

  • 26.1. South America Neonatal Point Of Care Testing Market Overview
  • 26.2. South America Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neonatal Point Of Care Testing Market

  • 27.1. Brazil Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neonatal Point Of Care Testing Market

  • 28.1. Middle East Neonatal Point Of Care Testing Market Overview
  • 28.2. Middle East Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neonatal Point Of Care Testing Market

  • 29.1. Africa Neonatal Point Of Care Testing Market Overview
  • 29.2. Africa Neonatal Point Of Care Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neonatal Point Of Care Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neonatal Point Of Care Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neonatal Point Of Care Testing Market Competitive Landscape And Company Profiles

  • 30.1. Neonatal Point Of Care Testing Market Competitive Landscape
  • 30.2. Neonatal Point Of Care Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neonatal Point Of Care Testing Market Other Major And Innovative Companies

  • 31.1. Drager Ag Co. Kg
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Masimo Corporation
  • 31.4. QIAGEN Inc.
  • 31.5. Radiometer Ltd.
  • 31.6. Contec Medical Systems Co. Ltd.
  • 31.7. Owen Mumford Ltd.
  • 31.8. Nova Biomedical
  • 31.9. Heal Force Bio Meditech Holdings Ltd.
  • 31.10. Edan Instruments Inc.
  • 31.11. Trivitron Healthcare
  • 31.12. Bistos Co. Ltd.
  • 31.13. Bilimetrix S.r.I
  • 31.14. GINEVRI srl
  • 31.15. Hadleigh Health Technologies

32. Global Neonatal Point Of Care Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Point Of Care Testing Market

34. Recent Developments In The Neonatal Point Of Care Testing Market

35. Neonatal Point Of Care Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Neonatal Point Of Care Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neonatal Point Of Care Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neonatal Point Of Care Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer